Fecal Microbiota Transplantation & Alcoholic hepatitis
Alcohol, liver disease and the gut microbiota.
Healthspan and lifespan extension by fecal microbiota transplantation into progeroid mice.
Fecal microbiota manipulation prevents dysbiosis and alcohol-induced liver injury in mice.
Liver-Microbiome Axis in Health and Disease.
Therapeutic advances in non-alcoholic fatty liver disease: A microbiota-centered view.
Non-alcoholic fatty liver diseases: from role of gut microbiota to microbial-based therapies.
Severe alcoholic hepatitis: current perspectives.
Alcohol or Gut Microbiota: Who Is the Guilty?
Intestinal microbiome and NAFLD: molecular insights and therapeutic perspectives.
Fecal microbiota transplantation in alcohol related liver diseases.
Microbiome as a therapeutic target in alcohol-related liver disease.
Microbiota-based treatments in alcoholic liver disease.
Role of Gut Dysbiosis in Liver Diseases: What Have We Learned So Far?
Microbiota, a key player in alcoholic liver disease.
Acute-on-chronic liver failure in patients with alcohol-related liver disease.
Regulating Intestinal Microbiota in the Prevention and Treatment of Alcohol-Related Liver Disease.
Molecular phenomics and metagenomics of hepatic steatosis in non-diabetic obese women.
Gut-liver axis, cirrhosis and portal hypertension: the chicken and the egg.
Intestinal Microbiota Modulation in Obesity-Related Non-alcoholic Fatty Liver Disease.
Targeting the gut microbiota to treat alcoholic liver diseases: evidence and promises.
Alcohol Addiction, Gut Microbiota, and Alcoholism Treatment: A Review.
The Candida albicans exotoxin candidalysin promotes alcohol-associated liver disease.
Intestinal microbiota in liver disease.
New paradigms in management of alcoholic hepatitis: a review.
[Medical Treatment of Alcoholic Liver Disease].
Gut Microbiota as a Therapeutic Target for Metabolic Disorders.
Microbial Metabolites: Critical Regulators in NAFLD.
Are Probiotics Effective in Targeting Alcoholic Liver Diseases?
Gut microbiome changes in Nonalcoholic fatty liver disease & alcoholic liver disease.
Current trials and novel therapeutic targets for alcoholic hepatitis.
Targeting Dysbiosis for the Treatment of Liver Disease.
A Role for Gut Microbiome Fermentative Pathways in Fatty Liver Disease Progression.
Treatment of Gut Fermentation Syndrome With Fecal Microbiota Transplantation.
Predictors of steroid non-response and new approaches in severe alcoholic hepatitis.
Healthy donor faecal transplant for corticosteroid non-responsive severe alcoholic hepatitis.